Source: Annual Congress 2011 - Rare diffuse lung diseases
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Fakharian, N. Mansouri, M. Karimi, A. Zamani, D. Mansouri (Tehran, Islamic Republic Of Iran). Pulmonary manifestations of systemic sclerosis, a report from Iran. Eur Respir J 2011; 38: Suppl. 55, 645

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019 Pulmonary manifestations of systemic vasculitis in childhood Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020 Year: 2020 Pulmonary functions in systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 Clinical and laboratory features of systemic sclerosis with pulmonary involvement Source: Eur Respir J 2001; 18: Suppl. 33, 512s Year: 2001 Pulmonary function in progressive systemic sclerosis Source: Eur Respir J 2002; 20: Suppl. 38, 62s Year: 2002 Stress-Doppler-Echocardiography for early detection of systemic sclerosis associated pulmonary arterial hypertension Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Pulmonary hypertension in systemic sclerosis: different phenotypes Source: Eur Respir Rev, 26 (145) 170056; 10.1183/16000617.0056-2017 Year: 2017 Systemic manifestations of sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 95s Year: 2006 Clinical feature of systemic sclerosis associated with pulmonary hypertension: results of one center study Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 Pulmonary arterial hypertension in systemic sclerosis: a distinctive endotheliopathy? Source: Eur Respir J 2010; 35: 223-224 Year: 2010 Hemoptysis: rare pulmonary manifestation of tuberous sclerosis in childhood Source: Eur Respir J 2006; 28: Suppl. 50, 544s Year: 2006 Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011 Screening for pulmonary arterial hypertension in systemic sclerosis Source: Eur Respir Rev 2009; 18: 162-169 Year: 2009 Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening Source: Eur Respir Rev 2011; 20: 270-276 Year: 2011 Sarcoidosis: pulmonary manifestations and management Source: Eur Respir Monogr 2019; 86: 404-418 Year: 2019 Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy Source: Eur Respir J 2009; 33: 371-379 Year: 2009 Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA Source: ERJ Open Res, 6 (2) 00309-2019; 10.1183/23120541.00309-2019 Year: 2020 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Pulmonary involvement and exercise limitation in patients with systemic sclerosis Source: Eur Respir J 2004; 24: Suppl. 48, 53s Year: 2004 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016